National Bank Of Canada Innate Pharma Sa Transaction History
National Bank Of Canada
- $73.7 Billion
- Q4 2024
A detailed history of National Bank Of Canada transactions in Innate Pharma Sa stock. As of the latest transaction made, National Bank Of Canada holds 450 shares of IPHA stock, worth $985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
450Holding current value
$985% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IPHA
# of Institutions
10Shares Held
138KCall Options Held
0Put Options Held
0-
Exchange Traded Concepts, LLC77.4KShares$169,3960.0% of portfolio
-
Morgan Stanley New York, NY43.5KShares$95,3170.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il11.9KShares$25,9580.0% of portfolio
-
Ubs Group Ag3.51KShares$7,6860.0% of portfolio
-
Rhumbline Advisers Boston, MA675Shares$1,4780.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $175M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...